Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the appointment of Robert ...

Abstract: The insulin pump is a critical device for intensive insulin therapy in diabetic patients. Failures in insulin pump sets such as blockage and leakage can disrupt normal insulin delivery, ...

Insulet Corporation (NASDAQ:PODD) ranks among the best medical device stocks to invest in. Canaccord Genuity maintained its Buy rating on Insulet Corporation (NASDAQ:PODD) and boosted its price target ...